The Comprehensive Treatment Regimen of Traditional Chinese Medicine ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 222 | Primary nephrotic syndrome | 1 |
222. Primary nephrotic syndrome
Clinical trials : 310 / Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01799460 (ClinicalTrials.gov) | December 2010 | 8/1/2013 | Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy | Mechanism Research of Traditional Chinese Medicine (the Comprehensive Treatment Regimen) in Treating Idiopathic Membranous Nephropathy by Genomewide Association Studies | Idiopathic Membranous Nephropathy | Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine;Drug: The immunosuppressive agents | Shanghai University of Traditional Chinese Medicine | NULL | Recruiting | 18 Years | 70 Years | Both | 80 | N/A | China |